Common use of Export Control Regulations Clause in Contracts

Export Control Regulations. The Subject Technology is subject to, and BELLICUM agrees to use commercially reasonable efforts to comply with, U.S. law including but not limited to U.S. export controls under the Export Administration Regulations (15 C.F.R. Part 734 et seq.) and U.S. economic sanctions and embargoes codified in 31 C.F.R. Chapter V. BELLICUM agrees that BELLICUM bears sole responsibility for understanding and complying with current U.S. trade controls laws and regulations as applicable to its activities subject to this Agreement. Without limitation on the general agreement to comply set forth in the first sentence of this Paragraph 13.3, BELLICUM agrees not to sell any goods, services, or technologies subject to this Agreement, or to re-export the same: (1) to any destination prohibited by U.S. law, including any destination subject to U.S. economic embargo; (2) to any end-user prohibited by U.S. law, including any person or entity listed on the U.S. government’s Specially Designated Nationals list, Denied Parties List, Debarred Persons List, Unverified List, or Entities List. Furthermore, any transfer of Patent Rights from BAYLOR to BELLICUM under this Agreement may be subject to U.S. export license authorization under U.S. law, and BAYLOR agrees to comply with applicable laws for such transfer.

Export Control Regulations. The Subject Technology is Patent Rights are subject to, and BELLICUM LICENSEE agrees to use commercially reasonable efforts to comply in all respects with, all applicable U.S. law export laws, including but not limited to U.S. export controls under the Export Administration Regulations (15 C.F.R. Part 734 et seq.) and U.S. economic sanctions and embargoes codified in 31 C.F.R. Chapter V. BELLICUM LICENSEE agrees that BELLICUM LICENSEE bears sole responsibility for understanding and complying with current U.S. trade controls laws and regulations as applicable to its activities subject to this Agreement. Without limitation on the general agreement to comply set forth in the first sentence of this Paragraph Section 13.3, BELLICUM LICENSEE agrees not to sell any goods, services, or technologies subject to this Agreement, or to release or disclose or re-export the same: (1i) to any destination prohibited by U.S. law, including any destination subject to U.S. economic embargo; (2ii) to any end-user prohibited by U.S. law, including any person or entity listed on the U.S. government’s Specially Designated Nationals list, Denied Parties List, Debarred Persons List, Unverified List, or Entities List; (iii) to any foreign national in the U.S. or abroad without prior license if required; or (iv) to any user, for any use, or to any destination without prior license if required by the US Government. Furthermore, LICENSEE agrees that any transfer of Patent Rights from BAYLOR BCM to BELLICUM LICENSEE under this Agreement may be subject to U.S. export license authorization as may be required under U.S. law, and BAYLOR agrees to comply with applicable laws for such transfer.

Export Control Regulations. The Subject Technology is subject to, and BELLICUM LICENSEE agrees to use commercially reasonable efforts to comply in all respects with, U.S. law including but not limited to U.S. export controls under the Export Administration Regulations (15 C.F.R. Part 734 et seq.) and U.S. economic sanctions and embargoes codified in 31 C.F.R. Chapter V. BELLICUM LICENSEE agrees that BELLICUM LICENSEE bears sole responsibility for understanding and complying with current U.S. trade controls laws and regulations as applicable to its activities subject to this Agreement. Without limitation on the general agreement to comply set forth in the first sentence of this Paragraph 13.314.3, BELLICUM LICENSEE agrees not to sell any goods, services, or technologies subject to this Agreement, or to release or disclose or re-export the same: (1i) to any destination prohibited by U.S. law, including any destination subject to U.S. economic embargo; (2ii) to any end-user prohibited by U.S. law, including any person or entity listed on the U.S. government’s 's Specially Designated Nationals list, Denied Parties List, Debarred Persons List, Unverified List, or Entities List; (iii) to any foreign national in the U.S. or abroad without prior license if required; or (iv) to any user, for any use, or to any destination without prior license if required. Furthermore, LICENSEE agrees that any transfer of Patent Rights from BAYLOR BCM to BELLICUM LICENSEE under this Agreement may be is subject to U.S. export license authorization as may be required under U.S. law, and BAYLOR agrees to comply with applicable laws for such transfer.

Export Control Regulations. The Subject Licensed Product, Licensed Technology is and Patent Rights are subject to, and BELLICUM Cell Medica agrees to use commercially reasonable efforts to comply in all respects with, U.S. law including but not limited to U.S. export controls under the Export Administration Regulations (15 C.F.R. Part 734 et seq.) and U.S. economic sanctions and embargoes codified in 31 C.F.R. Chapter V. BELLICUM Cell Medica agrees that BELLICUM Cell Medica bears sole responsibility for understanding and complying with current U.S. trade controls laws and regulations as applicable to its activities subject to this Agreement. Without limitation on the general agreement to comply set forth in the first sentence of this Paragraph Section 13.3, BELLICUM Cell Medica agrees not to sell any goods, services, or technologies subject to this Agreement, or to release or disclose or re-export the same: (1i) to any destination prohibited by U.S. law, including any destination subject to U.S. economic embargo; (2ii) to any end-user prohibited by U.S. law, including any person or entity listed on the U.S. government’s 's Specially Designated Nationals list, Denied Parties List, Debarred Persons List, Unverified List, or Entities List; (iii) to any foreign national in the U.S. or abroad without prior license if required; or (iv) to any user, for any use, or to any destination without prior license if required. Furthermore, Cell Medica agrees that any transfer of Patent Rights from BAYLOR Baylor to BELLICUM Cell Medica under this Agreement may be is subject to U.S. export license authorization as may be required under U.S. law, and BAYLOR agrees to comply with applicable laws for such transfer.. EXECUTION COPY CONFIDENTIAL Article XIV DISPUTE RESOLUTION

Export Control Regulations. The Subject Licensed Product, Licensed Technology is and Patent Rights are subject to, and BELLICUM Kuur agrees to use commercially reasonable efforts to comply in all respects with, U.S. law including but not limited to U.S. export controls under the Export Administration Regulations (15 C.F.R. Part 734 et seq.) and U.S. economic sanctions and embargoes codified in 31 C.F.R. Chapter V. BELLICUM Kuur agrees that BELLICUM Kuur bears sole responsibility for understanding and complying with current U.S. trade controls laws and regulations as applicable to its activities subject to this Agreement. Without limitation on the general agreement to comply set forth in the first sentence of this Paragraph Section 13.3, BELLICUM Kuur agrees not to sell any goods, services, or technologies subject to this Agreement, or to release or disclose or re-export the same: (1i) to any destination prohibited by U.S. law, including any destination subject to U.S. economic embargo; (2ii) to any end-user prohibited by U.S. law, including any person or entity listed on the U.S. government’s Specially Designated Nationals list, Denied Parties List, Debarred Persons List, Unverified List, or Entities List; (iii) to any foreign national in the U.S. or abroad without prior license if required; or (iv) to any user, for any use, or to any destination without prior license if required. Furthermore, Kuur agrees that any transfer of Patent Rights from BAYLOR Baylor to BELLICUM Kuur under this Agreement may be is subject to U.S. export license authorization as may be required under U.S. law, and BAYLOR agrees to comply with applicable laws for such transfer.

Export Control Regulations. The Subject Technology is subject to, and BELLICUM LICENSEE agrees to use commercially reasonable efforts to comply in all respects with, U.S. law including but not limited to U.S. export controls under the Export Administration Regulations (15 C.F.R. Part 734 et seq.) and U.S. economic sanctions and embargoes codified in 31 C.F.R. Chapter V. BELLICUM LICENSEE agrees that BELLICUM LICENSEE bears sole responsibility for understanding and complying with current U.S. trade controls laws and regulations as applicable to its activities subject to this Agreement. Without limitation on the general agreement to comply set forth in the first sentence of this Paragraph 13.314.3, BELLICUM LICENSEE agrees not to sell any goods, services, or technologies subject to this Agreement, or to release or disclose or re-export the same: (1i) to any destination prohibited by U.S. law, including any destination subject to U.S. economic embargo; (2ii) to any end-user prohibited by U.S. law, including any person or entity listed on the U.S. government’s Specially Designated Nationals list, Denied Parties List, Debarred Persons List, Unverified List, or Entities List; (iii) to any foreign national in the U.S. or abroad without prior license if required; or (iv) to any user, for any use, or to any destination without prior license if required. Furthermore, LICENSEE agrees that any transfer of Patent Rights from BAYLOR BCM to BELLICUM LICENSEE under this Agreement may be is subject to U.S. export license authorization as may be required under U.S. law, and BAYLOR agrees to comply with applicable laws for such transfer.